跳至主要内容
临床试验/NCT06956573
NCT06956573尚未招募不适用

Aortic Dimensions in Patients With Fabry Disease

University Hospital, Caen0 个研究点目标入组 200 人开始时间: 2025年5月2日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
200
主要终点
Maximum ascending aortic diameter measured by transthoracic echocardiography or cardiac MRI, expressed as a Z-score.

研究概览

简要总结

We will conduct a retrospective study aiming to define the characteristics, determinants, and progression of ascending aortic dilatation in adults with Fabry disease, using echocardiography and/or cardiac MRI

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • a adult patients with genetically confirmed Fabry disease must be able to signed informed consent for participation in the study

排除标准

  • Patient refusal to participate in the study

结局指标

主要结局

Maximum ascending aortic diameter measured by transthoracic echocardiography or cardiac MRI, expressed as a Z-score.

时间窗: At baseline

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Fabien LABOMBARDA

MD, PhD

University Hospital, Caen

相似试验